Pancreatic Cancer Therapy Market Growth and Recent Trends by 2025
- Status : Published
- Report Code : TIPAR00002009
- Category : Life Sciences
- No. of Pages : 133
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. INTRODUCTION 18
1.1 SCOPE OF THE STUDY 18
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 18
2. GLOBAL PANCREATIC CANCER THERAPY MARKET - KEY TAKEAWAYS 19
3. GLOBAL PANCREATIC CANCER THERAPY MARKET - MARKET LANDSCAPE 21
3.1 OVERVIEW 21
3.2 MARKET SEGMENTATION 21
3.3 GLOBAL PANCREATIC CANCER THERAPY MARKET - BY TYPE 22
3.4 GLOBAL PANCREATIC CANCER THERAPY MARKET - BY THERAPY 22
3.5 GLOBAL PANCREATIC CANCER THERAPY MARKET - BY GEOGRAPHY 23
3.6 PEST ANALYSIS 24
3.6.1 North America - PEST Analysis 24
3.6.2 Europe- PEST Analysis 26
3.6.3 Asia Pacific- PEST Analysis 28
3.6.4 Middle East And Africa- PEST Analysis 30
3.6.5 South and Central America - PEST Analysis 32
4. GLOBAL PANCREATIC CANCER THERAPY MARKET - KEY MARKET DYNAMICS 34
4.1 KEY MARKET DRIVERS 34
4.1.1 Rise in Number of Patients Suffering with Pancreatic Cancer 34
4.1.2 Increasing Healthcare Expenditures for Pancreatic Drugs 34
4.1.3 Increase in Number of Therapies Launched in the Market 35
4.2 KEY MARKET RESTRAINTS 35
4.2.1 Side Effects of the Therapies 35
4.2.2 Low Success Rate of Treatments 35
4.3 KEY MARKET OPPORTUNITIES 36
4.3.1 Development of Efficient Therapy for Pancreatic Cancer Treatment 36
4.4 FUTURE TRENDS 36
4.4.1 Rapid Adoption of Combination Therapy Over Monotherapy 36
4.5 IMPACT ANALYSIS 37
5. PANCREATIC CANCER THERAPY MARKET - GLOBAL ANALYSIS 38
5.1 GLOBAL PANCREATIC CANCER THERAPY MARKET REVENUE FORECASTS AND ANALYSIS 38
5.2 GLOBAL PANCREATIC CANCER THERAPY MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 39
5.3 EXPERT OPINIONS 40
6. PANCREATIC CANCER THERAPY MARKET ANALYSIS- BY TYPE 41
6.1 OVERVIEW 41
6.1.1 Endocrine Pancreatic Cancer 42
6.1.2 Overview 42
6.1.3 Global Endocrine Pancreatic Cancer Therapy Market Revenue and Forecasts to 2025 (US$ Mn) 42
6.1.4 Exocrine Pancreatic Cancer 43
6.1.4.1 Overview 43
6.1.4.2 Global Exocrine Pancreatic Cancer Therapy market Revenue and Forecasts to 2025 (US$ Mn) 43
7. GLOBAL PANCREATIC CANCER THERAPY MARKET ANALYSIS- BY THERAPY 44
7.1 OVERVIEW 44
7.2 BIOLOGIC THERAPY 45
7.2.1 Overview 45
7.2.2 Global Biologic Therapy Market Revenue and Forecasts to 2025 (US$ Mn) 45
7.3 CHEMOTHERAPY 46
7.3.1 Overview 46
7.3.2 Global Chemotherapy Market Revenue and Forecasts to 2025 (US$ Mn) 46
7.4 OTHERS 47
7.4.1 Overview 47
7.4.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn) 47
8. NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 48
8.1 OVERVIEW 48
8.2 NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49
8.3 NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 49
8.4 NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 50
8.5 NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 50
8.6 US PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
8.7 US PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
8.7.1 US Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn) 52
8.7.2 US Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn) 53
8.8 CANADA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
8.9 CANADA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
8.9.1 Canada Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn) 55
8.9.2 Canada Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn) 55
8.10 MEXICO PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56
8.11 MEXICO PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56
8.11.1 Mexico Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn) 57
8.11.2 Mexico Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn) 57
9. EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 58
9.1 OVERVIEW 58
9.2 EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
9.3 EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 59
9.4 EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 60
9.5 EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 60
9.6 GERMANY PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
9.6.1 Germany Pancreatic Cancer Therapy Market Revenue and Forecasts To 2025 (US$ Mn) 62
9.6.2 Germany Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn) 62
9.6.3 Germany Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn) 63
9.7 UK PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63
9.7.1 UK Pancreatic Cancer Therapy Market Revenue and Forecasts To 2025 (US$ Mn) 64
9.7.2 UK Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn) 64
9.7.3 UK Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn) 65
9.8 FRANCE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 66
9.8.1 France Pancreatic Cancer Therapy Market Revenue and Forecasts To 2025 (US$ Mn) 66
9.8.2 France Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn) 67
9.8.3 France Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn) 67
10. ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 68
10.1 OVERVIEW 68
10.2 ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 69
10.3 ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 69
10.4 ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 70
10.5 ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 70
10.6 JAPAN PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 71
10.7 JAPAN PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 71
10.7.1 Japan Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn) 72
10.7.2 Japan Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn) 72
10.8 CHINA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
10.9 CHINA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
10.9.1 China Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn) 74
10.9.2 China Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn) 74
10.10 INDIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75
10.11 INDIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
10.11.1 India Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn) 76
10.11.2 India Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn) 77
11. MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 78
11.1 OVERVIEW 78
11.2 MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79
11.3 MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 79
11.4 MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 80
11.5 MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 80
11.6 UAE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
11.7 UAE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
11.7.1 UAE Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn) 82
11.7.2 UAE Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn) 82
11.8 SAUDI ARABIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 82
11.9 SAUDI ARABIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
11.9.1 Saudi Arabia Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn) 83
11.9.2 Saudi Arabia Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn) 84
11.10 SOUTH AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 84
11.11 SOUTH AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 85
11.11.1 South Africa Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn) 85
11.11.2 South Africa Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn) 86
12. SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 87
12.1 OVERVIEW 87
12.2 SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88
12.3 SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 88
12.4 SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 89
12.5 SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET SHARE, BY COUNTRY (2017 & 2025) (%) 89
12.6 BRAZIL PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 90
12.6.1 Brazil Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025 (US$ Mn) 90
12.6.2 Brazil Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Type (US$ Mn) 91
12.6.3 Brazil Pancreatic Cancer Therapy Market Revenue And Forecasts to 2025, By Therapy (US$ Mn) 91
13. PANCREATIC CANCER THERAPY MARKET -INDUSTRY LANDSCAPE 92
13.1 OVERVIEW 92
13.2 GROWTH STRATEGIES IN THE PANCREATIC CANCER THERAPY MARKET, 2015-2018 92
13.3 ORGANIC DEVELOPMENTS 92
13.3.1 Overview 92
13.4 ORGANIC GROWTH STRATEGIES IN THE PANCREATIC CANCER THERAPY MARKET, 2015-2018 93
13.5 CLINICAL TRIALS 93
13.5.1 Recent Clinical Trials By Players In The Pancreatic Cancer Therapy Market 93
13.6 PRODUCT APPROVAL 94
13.6.1 Recent Product Approval By Players In The Pancreatic Cancer Therapy Market 94
13.7 OTHERS 94
13.7.1 Other Organic Developments In The Pancreatic Cancer Therapy Market 94
13.8 INORGANIC DEVELOPMENTS 95
13.8.1 Overview 95
13.9 INORGANIC GROWTH STRATEGIES IN THE PANCREATIC CANCER THERAPY MARKET, 2015-2018 95
13.10 COLLABORATION 96
13.10.1 Recent Collaborations by Players in the Pancreatic Cancer Therapy Market 96
13.11 OTHERS 96
13.11.1 Other Organic Developments In The Pancreatic Cancer Therapy Market 96
14. PANCREATIC CANCER THERAPY MARKET -KEY COMPANY PROFILES 97
14.1 ELI LILLY AND COMPANY 97
14.1.1 Key Facts 97
14.1.2 Business Description 97
14.1.3 Financial Overview 98
14.1.4 Product Portfolio 98
14.1.5 SWOT Analysis 98
14.1.6 Key Developments 99
14.2 F. HOFFMANN-LA ROCHE LTD. 100
14.2.1 Key Facts 100
14.2.2 Business Description 100
14.2.3 Financial Overview 101
14.2.4 Product Portfolio 101
14.2.5 Product Pipeline 101
14.2.6 SWOT Analysis 102
14.2.7 Key Developments 102
14.3 AMGEN INC. 103
14.3.1 Key Facts 103
14.3.2 Business Description 103
14.3.3 Financial Overview 104
14.3.4 Product Portfolio 104
14.3.5 Product Pipeline 104
14.3.6 SWOT Analysis 105
14.3.7 Key Developments 105
14.4 NOVARTIS AG 106
14.4.1 Key Facts 106
14.4.2 Business Description 106
14.4.3 Financial Overview 107
14.4.4 Product Portfolio 107
14.4.5 Product Pipeline 107
14.4.6 SWOT Analysis 108
14.4.7 Key Developments 108
14.5 CELGENE CORPORATION 109
14.5.1 Key Facts 109
14.5.2 Business Description 109
14.5.3 Financial Overview 110
14.5.4 Product Portfolio 110
14.5.5 SWOT Analysis 110
14.5.6 Key Developments 111
14.6 MERCK & CO., INC. 112
14.6.1 Key Facts 112
14.6.2 Business Description 112
14.6.3 Financial Overview 113
14.6.4 Product Portfolio 113
14.6.5 Product Pipeline 113
14.6.6 SWOT Analysis 114
14.6.7 Key Developments 114
14.7 PHARMACYTE BIOTECH INC. 116
14.7.1 Key Facts 116
14.7.2 Business Description 116
14.7.3 Financial Overview 117
14.7.4 Product Portfolio 117
14.7.5 SWOT Analysis 117
14.7.6 Key Developments 118
14.8 CLOVIS ONCOLOGY 119
14.8.1 Key Facts 119
14.8.2 Business Description 119
14.8.3 Financial Overview 120
14.8.4 Product Portfolio 120
14.8.5 SWOT Analysis 120
14.8.6 Key Developments 120
14.9 TEVA PHARMACEUTICAL INDUSTRIES LTD 121
14.9.1 Key Facts 121
14.9.2 Business Description 121
14.9.3 Financial Overview 122
14.9.4 Product Portfolio 122
14.9.5 SWOT Analysis 122
14.9.6 Key Developments 122
14.10 PFIZER INC. 123
14.10.1 Key Facts 123
14.10.2 Business Description 123
14.10.3 Financial Overview 124
14.10.4 Product Portfolio 124
14.10.5 SWOT Analysis 124
14.10.6 Key Developments 125
15. APPENDIX 126
15.1 ABOUT THE INSIGHT PARTNERS 126
15.2 GLOSSARY OF TERMS 127
15.3 METHODOLOGY 129
15.3.1 Coverage 130
15.3.2 Secondary Research 131
15.3.3 Primary Research 131
LIST OF TABLES
TABLE 1. NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 49
TABLE 2. NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 50
TABLE 3. US PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 52
TABLE 4. US PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 53
TABLE 5. CANADA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 55
TABLE 6. CANADA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 55
TABLE 7. MEXICO PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 57
TABLE 8. MEXICO PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 57
TABLE 9. EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 59
TABLE 10. EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 60
TABLE 11. GERMANY PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 62
TABLE 12. GERMANY PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 63
TABLE 13. UK PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 64
TABLE 14. UK PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 65
TABLE 15. FRANCE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 67
TABLE 16. FRANCE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 67
TABLE 17. ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 69
TABLE 18. ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 70
TABLE 19. ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 70
TABLE 20. JAPAN PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 72
TABLE 21. JAPAN PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 72
TABLE 22. CHINA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 74
TABLE 23. CHINA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 74
TABLE 24. INDIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 76
TABLE 25. INDIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 77
TABLE 26. MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 79
TABLE 27. MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 80
TABLE 28. UAE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 82
TABLE 29. UAE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 82
TABLE 30. SAUDI ARABIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 83
TABLE 31. SAUDI ARABIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 84
TABLE 32. SOUTH AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 85
TABLE 33. SOUTH AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 86
TABLE 34. SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 88
TABLE 35. SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$ MN) 89
TABLE 36. BRAZIL PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 91
TABLE 37. BRAZIL PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY THERAPY (US$MN) 91
TABLE 38. RECENT CLINICAL TRIALS IN THE PANCREATIC CANCER THERAPY MARKET 93
TABLE 39. RECENT PRODUCT APPROVAL IN THE PANCREATIC CANCER THERAPY MARKET 94
TABLE 40. OTHER ORGANIC DEVELOPMENTS IN THE PANCREATIC CANCER THERAPY MARKET 94
TABLE 41. RECENT COLLABORATIONS IN THE PANCREATIC CANCER THERAPY MARKET 96
TABLE 42. OTHER ORGANIC DEVELOPMENTS IN THE PANCREATIC CANCER THERAPY MARKET 96
TABLE 43. GLOSSARY OF TERMS, PANCREATIC CANCER THERAPY MARKET 127
LIST OF FIGURES
FIGURE 1. ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2025 19
FIGURE 2. GLOBAL PANCREATIC CANCER THERAPY MARKET BY TYPE, MARKET SHARE (%), 2017 20
FIGURE 3. GLOBAL PANCREATIC CANCER THERAPY MARKET BY THERAPY, MARKET SHARE (%), 2017 20
FIGURE 4. GLOBAL PANCREATIC CANCER THERAPY MARKET SEGMENTATION 21
FIGURE 5. GLOBAL PANCREATIC CANCER THERAPY MARKET SEGMENTATION, BY REGION 22
FIGURE 6. NORTH AMERICA PEST ANALYSIS 24
FIGURE 7. EUROPE PEST ANALYSIS 26
FIGURE 8. ASIA PACIFIC PEST ANALYSIS 28
FIGURE 9. MIDDLE EAST AND AFRICA PEST ANALYSIS 30
FIGURE 10. SOUTH AND CENTRAL AMERICA PEST ANALYSIS 32
FIGURE 11. PANCREATIC CANCER THERAPY MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 37
FIGURE 12. GLOBAL PANCREATIC CANCER THERAPY MARKET REVENUE FORECASTS AND ANALYSIS - 2017- 2025 38
FIGURE 13. GLOBAL PANCREATIC CANCER THERAPY MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2017- 2025 39
FIGURE 14. GLOBAL PANCREATIC CANCER THERAPY MARKET BREAKDOWN, BY PRODUCT 2017 & 2025 (%) 41
FIGURE 15. GLOBAL ENDOCRINE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 42
FIGURE 16. GLOBAL EXOCRINE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 43
FIGURE 17. GLOBAL PANCREATIC CANCER THERAPY MARKET SHARE, BY THERAPY 2017 & 2025 (%) 44
FIGURE 18. GLOBAL BIOLOGIC THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45
FIGURE 19. GLOBAL CHEMOTHERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 46
FIGURE 20. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 47
FIGURE 21. NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE, BY COUNTRY (2017) (US$ MN) 48
FIGURE 22. NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 49
FIGURE 23. NORTH AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 50
FIGURE 24. US PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
FIGURE 25. CANADA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
FIGURE 26. MEXICO PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56
FIGURE 27. EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE, BY COUNTRY (2017) (US$ MN) 58
FIGURE 28. EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
FIGURE 29. EUROPE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 60
FIGURE 30. GERMANY PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62
FIGURE 31. UK PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
FIGURE 32. FRANCE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 66
FIGURE 33. ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE, BY COUNTRY (2017) (US$ MN) 68
FIGURE 34. ASIA PACIFIC PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 69
FIGURE 35. JAPAN PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 71
FIGURE 36. CHINA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
FIGURE 37. INDIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
FIGURE 38. MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE, BY COUNTRY (2017) (US$ MN) 78
FIGURE 39. MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79
FIGURE 40. MIDDLE EAST AND AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 80
FIGURE 41. UAE PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
FIGURE 42. SAUDI ARABIA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
FIGURE 43. SOUTH AFRICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 85
FIGURE 44. SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE, BY COUNTRY (2017) (US$ MN) 87
FIGURE 45. SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 88
FIGURE 46. SOUTH AND CENTRAL AMERICA PANCREATIC CANCER THERAPY MARKET SHARE, BY COUNTRY (2017 & 2025) (%) 89
FIGURE 47. BRAZIL PANCREATIC CANCER THERAPY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 90
FIGURE 48. GROWTH STRATEGIES IN THE PANCREATIC CANCER THERAPY MARKET, 2015-2018 92
FIGURE 49. ORGANIC GROWTH STRATEGIES IN THE PANCREATIC CANCER THERAPY MARKET, 2015-2018 93
FIGURE 50. INORGANIC DEVELOPMENTS IN THE PANCREATIC CANCER THERAPY MARKET, 2015-2018 95
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For